Possibilities of therapy for early manifestations of chronic cerebral ischemia: results of the PROFILE program
Objective: to investigate the efficacy and safety of Cavinton® Comforte (Vinpocetine) in patients with initial manifestations of chronic cerebrovascular disease (CVD) in outpatient neurological and therapeutic practice.Patients and methods. The program included 4410 patients with a verified diagnosi...
Hoofdauteurs: | , , , |
---|---|
Formaat: | Artikel |
Taal: | Russian |
Gepubliceerd in: |
IMA-PRESS LLC
2017-11-01
|
Reeks: | Неврология, нейропсихиатрия, психосоматика |
Onderwerpen: | |
Online toegang: | https://nnp.ima-press.net/nnp/article/view/770 |